US-Swiss Trade Deal May Incorporate Assurance on Pharmaceutical Tariffs
1 week ago / Read about 0 minute
Author:小编   

The proposed trade agreement between the United States and Switzerland incorporates a unique provision aimed at affording preferential status to Switzerland in national security inquiries, thereby safeguarding its pharmaceutical exports from Section 232 tariffs. This clause is crafted to bolster cooperation between the two nations and avert potential tariff measures. The agreement has secured Swiss approval and now awaits ratification by President Trump of the United States to become enforceable.